(Press-News.org) Bottom Line: In patients with Alzheimer disease (AD), increased cerebrospinal fluid levels of orexin, which helps regulate the sleep-wake cycle, may be associated with sleep deterioration, which appears to be associated with cognitive decline.
Authors: Claudio Liguori, M.D., of the University of Rome Tor Vergata, Italy, and colleagues.
Background: AD is a neurodegenerative disease marked by progressive memory loss and cognitive decline and often complicated by sleep disturbance. Orexin A is part of the orexinergic system and it helps regulate the sleep-wake cycle by increasing arousal levels and maintaining wakefulness. A relationship between the orexinergic system and the AD neurodegenerative process has been examined in a few studies with conflicting results.
How the Study Was Conducted: The authors sought to evaluate the possible involvement of the orexinergic system by measuring CSF orexin levels in untreated AD patients and comparing them with healthy controls, as well as examining the role of the orexinergic system in sleep impairment in patients with AD. They measured CSF levels of orexin, the AD biomarkers tau proteins and β-amyloid 1-42, as well as assessing sleep variables (including total sleep time, sleep efficiency, sleep onset, rapid eye movement [REM] and non-REM sleep stages). The study from August 2012 through May 2013 included 48 untreated patients: 21 patients were included in the mild AD group and 27 were classified as having moderate to severe AD. There also was a group of 29 healthy controls.
Results: Patients with moderate to severe AD presented with higher average orexin levels compared with controls and they had more impaired sleep compared with controls and patients with mild AD. In the overall AD group, orexin levels were associated with total tau protein levels and sleep impairment. Cognitive impairment was associated with sleep deterioration.
Discussion: "Our study has shown that, in AD, increased CSF orexin levels are linked to a parallel sleep deterioration, which appears to be related to cognitive decline. Hence, our results demonstrate that, in AD, orexinergic output and function seem to be overexpressed with disease progression and severity, possibly owing to an imbalance in the neurotransmitter networks regulating the wake-sleep cycle toward the orexinergic system promoting wakefulness."
(JAMA Neurol. Published online October 13, 2014. doi:10.1001/.jamaneurol.2014.2510. Available pre-embargo to the media at http://media.jamanetwork.com.)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Editorial: Possible Role of Orexin in the Pathogenesis of Alzheimer
In a related commentary, Luigi Ferini-Strambi, M.D., Ph.D., of the Universitá Vita-Salute, Milan, Italy, writes: "Orexin is a neurotransmitter that plays a fundamental role in the regulation of the sleep-wake cycle by increasing arousal levels and maintaining wakefulness."
"The main finding of the study is the increase of orexin levels in patients with moderate-to-severe AD," he continues.
"Further research should clarity how to modify or improve sleep for mitigating the risk of future AD or for slowing AD progression. In particular, other studies on the role of arousal, sleep alterations and orexin in the pathogenesis of AD could suggest new preventive/therapeutic approaches," he concludes.
(JAMA Neurol. Published online October 13, 2014. doi:10.1001/.jamaneurol.2014.2819. Available pre-embargo to the media at http://media.jamanetwork.com.)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
INFORMATION:
Media Advisory: To contact author Claudio Liguori, M.D., email dott.claudioliguori@yahoo.it. To contact editorial author Luigi Ferini-Strambi, M.D., email ferinistrambi.luigi@hsr.it
Dysregulation in orexinergic system associated with Alzheimer disease
2014-10-13
ELSE PRESS RELEASES FROM THIS DATE:
Chemical derived from broccoli sprouts shows promise in treating autism
2014-10-13
Results of a small clinical trial suggest that a chemical derived from broccoli sprouts — and best known for claims that it can help prevent certain cancers — may ease classic behavioral symptoms in those with autism spectrum disorders (ASDs).
The study, a joint effort by scientists at MassGeneral Hospital for Children and the Johns Hopkins University School of Medicine, involved 40 teenage boys and young men, ages 13 to 27, with moderate to severe autism.
In a report published online in the journal Proceedings of the National Academy of Sciences during ...
Chemical present in broccoli, other vegetables may improve autism symptoms
2014-10-13
A small study led by investigators at MassGeneral Hospital for Children (MGHfC) and Johns Hopkins University School of Medicine has found evidence that daily treatment with sulforaphane – a molecule found in foods such as broccoli, cauliflower and cabbage – may improve some symptoms of autism spectrum disorders. In their report being published online in PNAS Early Edition, the investigators describe how participants receiving a daily dose of sulforaphane showed improvement in both behavioral and communication assessments in as little as four weeks. The authors ...
Greater rates of mitochondrial mutations discovered in children born to older mothers
2014-10-13
The discovery of a "maternal age effect" by a team of Penn State scientists that could be used to predict the accumulation of mitochondrial DNA mutations in maternal egg cells -- and the transmission of these mutations to children -- could provide valuable insights for genetic counseling. These mutations cause more than 200 diseases and contribute to others such as diabetes, cancer, Parkinson's disease, and Alzheimer's disease. The study found greater rates of the mitochondrial DNA variants in children born to older mothers, as well as in the mothers themselves. The research ...
Paving the way for a fructose tolerance test
2014-10-13
BOSTON – Increased consumption of table sugar and high-fructose corn syrup has been linked to rising rates of obesity and type 2 diabetes in the United States and throughout the world. Both sweeteners are commonly found in processed foods and sugar-sweetened beverages, and both are made up of nearly equal amounts of two basic sugars, glucose and fructose.
The effects of glucose ingestion in humans are well understood, in part, because they are easily assessed by performing a Glucose Tolerance Test, which measures serum glucose levels after glucose ingestion and ...
Moderate levels of 'free radicals' found beneficial to healing wounds
2014-10-13
Long assumed to be destructive to tissues and cells, "free radicals" generated by the cell's mitochondria—the energy producing structures in the cell—are actually beneficial to healing wounds.
That's the conclusion of biologists at UC San Diego who discovered that "reactive oxygen species"—chemically reactive molecules containing oxygen, such as peroxides, commonly referred to as free radicals—are necessary for the proper healing of skin wounds in the laboratory roundworm C. elegans.
In a paper published in the October 13 issue of the journal ...
New cancer drug to begin trials in multiple myeloma patients
2014-10-13
Scientists at Imperial College London have developed a new cancer drug which they plan to trial in multiple myeloma patients by the end of next year.
In a paper published today in the journal Cancer Cell, the researchers report how the drug, known as DTP3, kills myeloma cells in laboratory tests in human cells and mice, without causing any toxic side effects, which is the main problem with most other cancer drugs. The new drug works by stopping a key process that allows cancer cells to multiply.
The team have been awarded Biomedical Catalyst funding from the Medical ...
A new land snail species named for equal marriage rights
2014-10-13
Scientists from the Department of Life Science, National Taiwan Normal University and the Biodiversity Research Center, Academia Sinica described a new endemic land snail species. The new species Aegista diversifamilia was long confused for the widely distributed A. subchinensis. The study was published in the open access journal ZooKeys.
Aegista subchinensis was first described in 1884 and was thought to be widely distributed in Taiwan. In 2003, one of the co-authors Dr. Yen-Chang Lee noticed that there was morphological divergence between the western and eastern populations ...
Versatile antibiotic found with self-immunity gene on plasmid in staph strain
2014-10-13
WASHINGTON, DC – OCTOBER 10, 2014 - A robust, broad spectrum antibiotic, and a gene that confers immunity to that antibiotic are both found in the bacterium Staphylococcus epidermidis Strain 115. The antibiotic, a member of the thiopeptide family of antibiotics, is not in widespread use, partly due to its complex structure, but the investigators, from Brigham Young University, Provo, Utah, now report that the mechanism of synthesis is surprisingly simple. "We hope to come up with innovative processes for large-scale production and derivitization so that new, and possibly ...
Tailored flexible illusion coatings hide objects from detection
2014-10-13
Developing the cloak of invisibility would be wonderful, but sometimes simply making an object appear to be something else will do the trick, according to Penn State electrical engineers.
"Previous attempts at cloaking using a single metasurface layer were restricted to very small-sized objects," said Zhi Hao Jiang, postdoctoral fellow in electrical engineering, Penn State. "Also, the act of cloaking would prevent an enclosed antenna or sensor from communicating with the outside world."
Jiang and Douglas H. Werner, John L. and Genevieve H. McCain Chair Professor of ...
Stanford scientists create a 'smart' lithium-ion battery that warns of fire hazard
2014-10-13
Stanford University scientists have developed a "smart" lithium-ion battery that gives ample warning before it overheats and bursts into flames.
The new technology is designed for conventional lithium-ion batteries now used in billions of cellphones, laptops and other electronic devices, as well as a growing number of cars and airplanes.
"Our goal is to create an early-warning system that saves lives and property," said Yi Cui, an associate professor of materials science and engineering at Stanford. "The system can detect problems that occur during the normal operation ...